1. Home
  2. MYGN vs AVNS Comparison

MYGN vs AVNS Comparison

Compare MYGN & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.65

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Avanos Medical Inc.

AVNS

Avanos Medical Inc.

HOLD

Current Price

$13.08

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
AVNS
Founded
1991
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
521.7M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
MYGN
AVNS
Price
$4.65
$13.08
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$7.64
N/A
AVG Volume (30 Days)
1.7M
583.1K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
81.59
EPS
N/A
N/A
Revenue
$771,400,000.00
$701,200,000.00
Revenue This Year
$7.19
$3.28
Revenue Next Year
$5.64
$4.23
P/E Ratio
N/A
N/A
Revenue Growth
2.33
1.95
52 Week Low
$3.76
$9.30
52 Week High
$10.25
$15.68

Technical Indicators

Market Signals
Indicator
MYGN
AVNS
Relative Strength Index (RSI) 42.83 40.25
Support Level $3.93 $12.75
Resistance Level $5.63 $13.11
Average True Range (ATR) 0.33 0.51
MACD 0.00 -0.08
Stochastic Oscillator 23.53 22.70

Price Performance

Historical Comparison
MYGN
AVNS

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Share on Social Networks: